Biomarker - Latest News  

RayBiotech today announced the establishment of its Biomarker Discovery Pilot Grant program, consisting of restricted grants of $10,000 to $20,000 worth of RayBiotech products and services for protein biomarker discovery.

Lee Biosolutions is involved with the development and purification of the next generation of cardiovascular biomarkers that has the potential of not only improving but also the ability to better treat patients with chronic and acute heart failure.

The global biomarker market is estimated to be $20.5 billion by 2014, growing at a CAGR of 19.7 % from 2009 to 2014, driven by the high demand for the biomarkers in the field of drug discovery.

Global alliance enables gene expression profiling from challenging clinical samples

Ocimum Biosolutions now offers complete sequencing solution to all reserach , pharma and biotech laboratories

GTCbio just announced its 2nd Annual Oncology Biomarkers Conference taking place on January 19-20, 2009 in Miami, Florida.

Cambridge Research Biochemicals (CRB) has signed an agreement with Panagene to become the UK distributor for high purity peptide nucleic acids (PNA) oligomers. PNAs have many applications in bio-procedures, diagnostics, and anti-gene therapies.

C-Reactive Protein is a protein found in the blood that operates as a marker for inflammation, meaning its presence indicates an increased state of inflammation in the body. Lee Biosolutions is a preferred supplier for the clinical diagnostic market

Kenna Anderes of Pfizer Global R&D, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference on January 14-15, 2008.